Compare Cronos Group Inc (CRON) vs State Street SPDR S&P Homebuilders ETF (XHB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs State Street SPDR S&P Homebuilders ETF — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while State Street SPDR S&P Homebuilders ETF trades at $94.77 (market cap $1.49B). The key difference: State Street SPDR S&P Homebuilders ETF is the larger of the two by market cap, and Cronos Group Inc is trading nearer its 52-week high, State Street SPDR S&P Homebuilders ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and State Street SPDR S&P Homebuilders ETF for 33 Days on average.
| CRON | XHB | |
|---|---|---|
Market Cap | $1.18B | $1.49B |
Volume | 968,037 | 2,445,587 |
Sector | Health | Broad Market / Factor |
52-Week High | $3.55 | $121.36 |
52-Week Low | $2.30 | $94.77 |
Typical Hold Time | 22 Days | 33 Days |
Enterprise Value | $387.62M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.22, down 0.62% on the day, amid a bearish technical signal. The stock shows mixed earnings history, with recent beats in Q1 and Q2 2026 but a miss in Q4 2025. Revenue growth is robust, increasing from $118M in 2024 to $147M in 2025, with a projected rise to $179M in 2026. However, profitability remains volatile, with a net loss of $9.45M in 2025 despite a strong gross margin of 45.86%. Recent news highlights the company's Investor Day focusing on global expansion and cash flow generation.
The outlook for CRON is cautiously optimistic, driven by international growth and a debt-free balance sheet with $827M in cash. Key risks include ongoing profitability challenges, competitive pressures, and regulatory uncertainties in the cannabis sector. Analyst sentiment is mixed, with 60% hold ratings, suggesting a wait-and-see approach. Investors should weigh strong revenue trends against execution risks and margin volatility.
XHB (SPDR S&P Homebuilders ETF) trades at $95.66, up 0.81% with a bearish technical signal from moving averages. The ETF faces headwinds from rising mortgage rates above 7% but shows potential catalysts from new housing legislation and institutional interest. Recent news highlights mixed housing data with June new home sales rising 1.6% while existing home sales declined 2.4%, creating uncertainty in the housing sector.
The homebuilder ETF presents a contrarian opportunity amid sector weakness, with historical valuation signals suggesting potential rebounds. Key risks include persistent high mortgage rates and housing affordability challenges, while positive catalysts include institutional accumulation and government housing support measures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About State Street SPDR S&P Homebuilders ETF
XHB invests in the U.S. homebuilding industry and related sectors. It provides equal-weighted exposure to homebuilders, building products, and home improvement retailers like Home Depot, Lowe's, and Builders FirstSource.
Read more on XHB →
